The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Mutation and copy number discordance in primary versus metastatic colorectal cancer (mCRC).
Scott Kopetz
No relevant relationships to disclose
Michael J. Overman
No relevant relationships to disclose
Ken Chen
No relevant relationships to disclose
Agda Karina Lucio-Eterovic
No relevant relationships to disclose
Bryan K. Kee
No relevant relationships to disclose
David R. Fogelman
No relevant relationships to disclose
Arvind Dasari
No relevant relationships to disclose
Kanwal Pratap Singh Raghav
No relevant relationships to disclose
Eduardo Vilar Sanchez
No relevant relationships to disclose
Jonathan Phillips
No relevant relationships to disclose
Imad Shureiqi
No relevant relationships to disclose
Chris R. Garrett
No relevant relationships to disclose
Robert A. Wolff
No relevant relationships to disclose
Keyur Patel
No relevant relationships to disclose
Kenneth D. Aldape
No relevant relationships to disclose
Rajyalakshmi Luthra
No relevant relationships to disclose
Mark Routbort
No relevant relationships to disclose
Dipen M. Maru
No relevant relationships to disclose
Funda Meric-Bernstam
No relevant relationships to disclose
Cathy Eng
No relevant relationships to disclose